| Typicality: | 0.497 |
| Saliency: | 0.503 |
| in preventing cardiovascular events | 8 | transitive-object |
| compared to therapeutic nd | 6 | other |
| in ipsilateral breast tumor recurrence | 5 | other |
| trial → show → benefit | 38 |
| trial → find → benefit | 12 |
| trial → suggest → benefit | 8 |
| trial → demonstrate → benefit | 7 |
| trial → found → benefit | 4 |
| negative | neutral | positive |
| 0.159 | 0.451 | 0.390 |
| Raw frequency | 69 |
| Normalized frequency | 0.503 |
| Modifier score | 0.600 |
| Perplexity | 168.341 |